Food, Health & Wellness News
-
FendX Discusses Recent CDC Report on the Rise of Six Superbug Infections in the US
CDC reports burden of six hard-to-treat superbugs increased by a combined 20% in 2021 and 2022 compared with…
-
FendX Completes Successful Pilot Scale-Up Run of REPELWRAP(TM) Film with Dunmore
July 24, 2024 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”) a nanotechnology…
-
FendX Announces Grant of Stock Options and RSUs
July 18, 2024 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”), a…
-
FendX Announces Sixth Real-World Testing Site for REPELWRAP(TM) Film with LA Fitness
Real-World testing nanotechnology to provide insights for manufacturing process with Dunmore July 16, 2024 (Source) — FendX Technologies…
-
FendX Technologies Inc. Comments on Recent Promotional Activity Pursuant to OTC Markets Request
June 24, 2024 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”)…
-
FendX Provides Corporate Update
Advancing our Nanotechnology toward Commercialization through Achievement of Key Milestones June 20, 2024 (Source) — FendX Technologies Inc.…
-
FendX Announces Fifth Real-World Testing Site for REPELWRAP(TM) Film with New Vista Society, a Long-Term Care and Senior Housing Provider
Testing nanotechnology to assess for further optimization of manufacturing process at Dunmore June 12, 2024 (Source) — FendX…
-
Sage Potash Grants Stock Options
June 7, 2024 (Source) — Sage Potash Corp., (TSXV: SAGE) (OTC: SGPTF) (“Sage” or the “Company”) has granted an aggregate of…
-
FendX’s Nanotechnology to be Presented at the Infection Prevention and Control Canada National Conference
June 6, 2024 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”), a…
-
FendX Commences Trading on Germany’s Tradegate Exchange
June 5, 2024 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”),…
